Sophiris Bio Inc.

๐Ÿ“ La Jolla, United States๐Ÿ‘ฅ 5 employees๐Ÿ’ฐ Last funded 2013
Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
โ€”
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sophiris Bio Inc.?
Sophiris Bio Inc. has 1 investors on record on gritt.io.
When did Sophiris Bio Inc. last raise funding?
The most recent investment in Sophiris Bio Inc. recorded on gritt.io was in 2013.
What industry is Sophiris Bio Inc. in?
Sophiris Bio Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Sophiris Bio Inc. based?
Sophiris Bio Inc. is headquartered in La Jolla, United States.